Stronger order intake, but lower sales Cavotec reported order intake of EUR 44m (+7% vs.
Redeye notes that Gapwaves' Q2 2025 report exceeded its estimates on all key metrics.
Redeye is happy to see OXE Marine beating our forecasts across the board.
Redeye comments on Polygiene Group´s Q2 2025. Polygiene Group delivered negative growth of -12% y/y.
Sales and EBIT miss of SEK 22m and 7m vs. ABGSCe This afternoon, Energy Save issued a profit warning...
Mentice is in the process of making the business sharper, more focused, and more efficient.
Prisma redovisade en stark Q2 med 15,5 % högre intäkter och ett förvaltningsresultat på 48 Mkr (11).
Hanza levererade ett starkt Q2 med 3 % organisk tillväxt och rörelseresultat på 97 Mkr, i linje med ...
Redeye provides its initial take on MedCap’s Q2 2025 report, which roughly matched our top-line proj...
Q2 yet another miss As feared, Invisio faced tough comps in Q2 and missed expectations across most k...
Q2 results Sales fell 3% y-o-y and were 7% below our estimate.
Uncertainty remains The uncertainties regarding tariffs have not diminished during the months foll...
Redeye provides a brief comment on FMG’s downward revision of its full-year guidance.
OEM challenges delay ramp-up, again CTT continues to suffer from supply chain challenges at its cust...
Beijer Alma levererar en mycket stark kvartalsrapport som visar på både organisk och men främst förv...
